You are here


The Center for Integration of Science and Industry is proud to present the Innovator’s Business Series

The Innovator's Business Series features talks and informal discussions with thought leaders from academia and industry focused on best practices in translational science. Speakers present the perspective of successful innovators in translating scientific advances into public value. The theme of the series centers on the need for integrating technological and business innovation in the fields of biotechnology, healthcare, high-tech and alternative energy.

Complete list of past events


Upcoming Programs

Biotechnology Mini-MBA

Fred Ledley discusses Bentley’s biotechnology mini-MBA and what it offers you and your company. WATCH VIDEO

Next dates TBD


Recent Programs

Frugal Innovation Creating a Path to a Healthier Society

Wednesday, February 20, 2019 @ 5:00 PM | Wilder Pavilion, Bentley University

Businesses have the power to democratize innovation. However, the incentives of the business model are key to its outcomes. This fireside chat with Dr. Gary Nabel centered on frugal innovation and how economic incentives can align with good public health outcomes to de-risk the business of saving lives.

Dr. Gary J. Nabel, M.D., Ph.D., is Chief Scientific Officer, Global Research and Development, and Head of the North American R&D Hub at Sanofi. In addition to serving as Senior Vice President for the company, Dr. Nabel also oversees the Breakthrough Lab, which developed the first trispecific antibodies now in development for HIV as published in Science, as well as, cancer immunotherapies and novel vaccines.  The Chief Scientific Office sponsors the iAwards, the Postdoctoral and Innovation Fellows Programs, and the Global Science Awards.


Past Speakers

  • Phillip A. Sharp

    Institute Professor, Massachusetts Institute of Technology
    Koch Institute for Integrative Cancer Research

  • Katherine Clark

    Massachusetts Congresswoman

  • Lance Colwell ’92

    Former Vice President for the U.S. Rare Disease Group at Biogen

  • Wildon Farwell, MD, MPH

    Senior Medical Director of Clinical Development at Biogen

  • Matt Kapusta

    CEO, uniQure

  • Calestous Juma

    Professor, Practice of International Development
    Director, Science, Technology, and Globalization Project
    Faculty Chair of the Mason Fellows Program
    Belfer Center for Science and International Affairs
    Harvard Kennedy School

  • Governor Michael Dukakis

    Distinguished Professor of Political Science, Northeastern University
    Governor of Massachusetts (1975-1979, 1983-1991)
    1988 Democratic Nominee for President of the United States

  • Robert Anderson

    Former General Council, BASF Bioresearch

  • Robert Kamen

    Former President, BASF Bioresearch

  • Robert Coughlin

    President & CEO, MassBio

  • Sandra L. Fenwick

    President and Chief Executive Officer of Boston Children's Hospital

  • Donald M. Berwick

    President Emeritus and Senior Fellow of the Institute for Healthcare Improvement
    Formerly the Administrator of the Centers for Medicare & Medicaid Services

  • Joshua Boger

    Executive Chairman, Alkeus Pharmaceuticals, Inc.
    Formerly the President, CEO and Chairman of Vertex Pharmaceuticals

  • Nick Donofrio

    Executive Vice-President for Technology and Innovation, IBM (retired)

  • Deborah Dunsire

    President and CEO of Envivo Pharmaceuticals

  • Susan Windham-Bannister

    Formerly the President and CEO of Massachusetts Life Sciences Center